Page 6 - Restricted Use News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Get latest articles and stories on India at LatestLY. iNCOVACC, on Tuesday, became the world's first intra-nasal vaccine to receive both Primary series and Heterologous booster approval, Bharat Biotech International Limited (BBIL) announced India News | India-made INCOVACC, World's First Intra-nasal Vaccine to Receive Approval for Both Primary Series, Heterologous Booster.

INCOVACC, on Tuesday, became the world's first intra-nasal vaccine to receive both Primary series and Heterologous booster approval, Bharat Biotech International Limited (BBIL) announced in a press release.

For individuals 18 years of age and older, the DCGI has authorised the use of Bharat Biotech's five arms heterologous booster, ANI reported.

The Subject Expert Committee (SEC) members of the Drugs Controller General of India (DCGI) are going to meet on November 15 and hold a discussion on intranasal

Bharat Biotech has applied for market authorisation from the Drugs Controller General of India (DCGI) for intranasal heterologous booster, sources told ANI.